MedPath

TEVA-DOXYLAMINE/PYRIDOXINE DR

TEVA-DOXYLAMINE/PYRIDOXINE DR

Approved
DIN Number

02304503

Drug Class

Human

Market Date

N/A

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02304503
AIG Number0213346001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R06AA59 DOXYLAMINE, COMBINATIONS
Product Specifications
Dosage FormTablet (Delayed-Release)
Route of AdministrationOral
AHFS Classification56:22.08
Health Canada Classification

ACTIVE INGREDIENTS (2)

DOXYLAMINE SUCCINATEActive
Strength: 10 MG
Monograph: DOXYLAMINE SUCCINATE
PYRIDOXINE HYDROCHLORIDEActive
Strength: 10 MG
Monograph: PYRIDOXINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.